Parsons (PSN) Financials

$62.71 +1.69 (+2.77%)

Closing price 05/6/2025 03:59 PM Eastern

Extended Trading

$62.70 -0.01 (-0.02%)

As of 04:35 AM Eastern

Annual Income Statements for Parsons

This table shows Parsons' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/29/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	97	222	121	99	64	97	161	235
Consolidated Net Income / (Loss)	112	239	137	119	89	127	208	291
Net Income / (Loss) Continuing Operations	112	239	137	119	89	127	208	291
Total Pre-Tax Income	133	260	67	161	113	166	264	368
Total Operating Income	151	205	92	178	132	186	288	428
Total Gross Profit	617	766	832	877	853	947	1,206	1,406
Total Revenue	3,017	3,561	3,955	3,919	3,661	4,195	5,443	6,751
Operating Revenue	3,017	3,561	3,955	3,919	3,661	4,195	5,443	6,751
Total Cost of Revenue	2,400	2,795	3,123	3,042	2,808	3,249	4,237	5,344
Operating Cost of Revenue	2,400	2,795	3,123	3,042	2,808	3,249	4,237	5,344
Total Operating Expenses	466	560	740	699	720	761	918	955
Selling, General & Admin Expense	506	597	781	729	757	777	870	955
Total Other Income / (Expense), net	-18	55	-25	-16	-20	-19	-24	-84
Interest Expense	16	21	24	21	18	23	31	70
Interest & Investment Income	2.47	2.71	1.30	0.79	0.40	0.97	2.19	-12
Other Income / (Expense), net	-4.37	73	-2.39	3.77	-2.56	2.78	5.00	-1.91
Income Tax Expense	21	20	-70	42	24	40	56	77
Net Income / (Loss) Attributable to Noncontrolling Interest	14	17	17	20	25	30	47	56
Basic Earnings per Share	$1.16	$2.78	$1.30	$0.98	$0.62	$0.93	$1.53	$2.21
Weighted Average Basic Shares Outstanding	-	-	100.67M	102.36M	103.67M	104.71M	105.83M	106.78M
Diluted Earnings per Share	$1.16	$2.78	$1.30	$0.97	$0.59	$0.87	$1.42	$2.12
Weighted Average Diluted Shares Outstanding	-	-	100.67M	102.36M	103.67M	104.71M	105.83M	106.78M
Weighted Average Basic & Diluted Shares Outstanding	-	-	100.67M	102.36M	103.67M	104.71M	105.83M	106.78M

This table shows Parsons' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	30	28	26	43	47	45	-107	69	72	201	66
Consolidated Net Income / (Loss)	44	36	35	55	60	58	-92	81	86	216	82
Net Income / (Loss) Continuing Operations	44	36	35	55	60	58	-92	81	86	216	82
Total Pre-Tax Income	57	48	47	70	75	72	-124	103	108	281	101
Total Operating Income	64	59	51	76	83	77	102	111	115	100	109
Total Gross Profit	262	243	256	288	294	367	325	352	360	370	354
Total Revenue	1,134	1,103	1,173	1,356	1,419	1,494	1,536	1,670	1,810	1,734	1,554
Operating Revenue	1,134	1,103	1,173	1,356	1,419	1,494	1,536	1,670	1,810	1,734	1,554
Total Cost of Revenue	872	860	917	1,068	1,124	1,127	1,211	1,319	1,450	1,365	1,200
Operating Cost of Revenue	872	860	917	1,068	1,124	1,127	1,211	1,319	1,450	1,365	1,200
Total Operating Expenses	198	184	205	212	211	290	223	240	245	247	245
Selling, General & Admin Expense	197	195	199	212	221	238	221	223	246	265	244
Other Operating Expenses / (Income)	0.97	-	5.84	-0.08	-10	52	2.06	17	-0.87	-	0.69
Total Other Income / (Expense), net	-6.63	-11	-4.35	-6.45	-8.31	-5.19	-226	-8.29	-6.88	158	-8.47
Interest Expense	6.32	8.40	6.46	7.30	8.61	9.13	224	13	13	-180	12
Interest & Investment Income	0.38	-5.25	0.79	0.31	0.49	0.60	1.15	3.83	4.23	-21	2.14
Other Income / (Expense), net	-0.69	3.08	1.31	0.54	-0.19	3.34	-3.33	0.90	1.92	-1.40	1.64
Income Tax Expense	14	12	12	15	15	14	-32	22	23	64	19
Net Income / (Loss) Attributable to Noncontrolling Interest	14	8.22	9.72	12	12	13	15	12	14	15	16
Basic Earnings per Share	$0.29	$0.26	$0.24	$0.41	$0.45	$0.43	($1.01)	$0.65	$0.68	$1.89	$0.62
Weighted Average Basic Shares Outstanding	103.50M	104.71M	104.86M	104.89M	104.89M	105.83M	146.75M	106.19M	106.19M	106.78M	106.87M
Diluted Earnings per Share	$0.27	$0.24	$0.23	$0.38	$0.42	$0.39	($1.01)	$0.63	$0.65	$1.85	$0.60
Weighted Average Diluted Shares Outstanding	103.50M	104.71M	104.86M	104.89M	104.89M	105.83M	146.75M	106.19M	106.19M	106.78M	106.87M
Weighted Average Basic & Diluted Shares Outstanding	103.50M	104.71M	104.86M	104.89M	104.89M	105.83M	146.75M	106.19M	106.19M	106.78M	106.87M

This table details how cash moves in and out of Parsons' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/29/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	53	-165	-86	292	-143	-81	10	181
Net Cash From Operating Activities	265	285	220	289	206	238	408	524
Net Cash From Continuing Operating Activities	265	285	220	289	206	238	408	524
Net Income / (Loss) Continuing Operations	112	239	137	119	89	127	208	291
Consolidated Net Income / (Loss)	112	239	137	119	89	127	208	291
Depreciation Expense	35	70	126	128	144	121	120	99
Amortization Expense	-6.78	-6.53	0.97	5.19	2.82	3.03	2.84	7.80
Non-Cash Adjustments To Reconcile Net Income	59	-364	27	60	65	60	154	226
Changes in Operating Assets and Liabilities, net	66	346	-71	-23	-95	-72	-77	-100
Net Cash From Investing Activities	-53	-503	-571	-346	-241	-417	-376	-557
Net Cash From Continuing Investing Activities	-53	-503	-571	-346	-256	-417	-376	-557
Purchase of Property, Plant & Equipment	-28	-29	-68	-34	-21	-31	-40	-49
Acquisitions	-29	-486	-519	-314	-237	-397	-342	-563
Sale of Property, Plant & Equipment	2.25	0.44	3.79	1.55	1.33	0.77	0.55	0.18
Divestitures	-	-	0.00	0.00	0.00	0.00	0.38	0.00
Sale and/or Maturity of Investments	1.97	11	12	0.05	0.77	9.44	5.02	55
Net Cash From Financing Activities	-160	55	266	348	-107	100	-22	219
Net Cash From Continuing Financing Activities	-160	55	266	348	-102	100	-22	219
Repayment of Debt	-1.95	-81	-777	-223	-50	-1,171	-621	628
Repurchase of Preferred Equity	-	-	-	-	-	0.00	0.00	-498
Repurchase of Common Equity	-	-	-6.27	0.00	-22	-33	-11	-25
Payment of Dividends	-51	-19	-94	-5.82	-38	-24	-12	-29
Issuance of Debt	0.00	260	597	613	0.00	1,320	621	153
Issuance of Common Equity	7.48	21	547	20	7.31	16	8.93	10
Other Financing Activities, net	-114	-126	0.00	-56	0.00	-7.04	-7.30	-20
Effect of Exchange Rate Changes	1.24	-1.70	-1.29	0.82	-1.50	-1.77	0.55	-5.04
Cash Interest Paid	13	17	23	14	15	21	30	34
Cash Income Taxes Paid	14	17	60	55	22	32	74	65

This table details how cash moves in and out of Parsons' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	21	115	-42	-42	27	68	150	105	30	-105	-184
Net Cash From Operating Activities	123	89	-8.99	23	204	190	-63	161	299	127	-12
Net Cash From Continuing Operating Activities	123	89	-8.99	23	204	190	-63	161	299	127	-12
Net Income / (Loss) Continuing Operations	44	36	35	55	60	58	-92	81	86	216	82
Consolidated Net Income / (Loss)	44	36	35	55	60	58	-92	81	86	216	82
Depreciation Expense	30	30	28	29	30	33	25	24	25	26	27
Amortization Expense	0.66	1.07	0.66	0.76	0.71	0.72	4.10	1.23	1.24	1.24	1.22
Non-Cash Adjustments To Reconcile Net Income	-14	47	-14	-3.34	-7.43	179	246	11	60	-90	-36
Changes in Operating Assets and Liabilities, net	63	-25	-59	-58	120	-80	-245	44	128	-27	-86
Net Cash From Investing Activities	1.16	-15	-21	-63	-243	-49	-46	-43	-256	-212	-62
Net Cash From Continuing Investing Activities	1.16	-15	-21	-63	-243	-49	-46	-43	-256	-212	-62
Purchase of Property, Plant & Equipment	-6.20	-11	-8.15	-9.81	-13	-9.52	-9.44	-9.26	-12	-19	-13
Acquisitions	-2.41	-4.18	-13	-54	-230	-44	-36	-34	-244	-248	-48
Sale of Property, Plant & Equipment	0.32	0.20	0.02	0.05	0.21	0.27	0.00	0.05	0.08	0.05	0.00
Net Cash From Financing Activities	-102	40	-13	-1.68	67	-74	260	-12	-13	-15	-111
Net Cash From Continuing Financing Activities	-102	40	-13	-1.68	67	-74	260	-12	-13	-15	-111
Repayment of Debt	-433	-590	-5.70	-182	-249	-184	-172	-0.24	-	800	-146
Repurchase of Preferred Equity	-	-	0.00	-	-	-	-496	-	-0.02	-2.02	-28
Repurchase of Common Equity	-3.95	-2.50	-6.00	-2.00	-	-3.00	0.00	-10	-	-15	-25
Payment of Dividends	-3.95	-9.84	-0.64	-1.85	-9.67	-0.34	-11	-3.99	-14	-0.19	-42
Issuance of Debt	334	639	5.70	182	324	109	953	-	-	-800	146
Issuance of Common Equity	5.47	4.62	0.20	2.94	1.34	4.45	0.00	3.82	0.96	5.33	0.26
Other Financing Activities, net	-0.17	-0.91	-6.06	-0.77	-0.10	-0.36	-15	-2.03	-0.29	-3.33	-16
Effect of Exchange Rate Changes	-1.26	0.45	0.15	0.31	-0.30	0.38	-0.40	-0.24	0.33	-4.72	0.52

This table presents Parsons' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	2,613	3,450	3,938	3,831	4,198	4,804	5,488
Total Current Assets	1,489	1,526	1,843	1,632	1,720	2,138	2,462
Cash & Equivalents	280	183	484	343	263	273	454
Restricted Cash	0.97	13	3.61	1.28	0.00	0.00	0.00
Accounts Receivable	623	671	699	598	717	916	1,100
Prepaid Expenses	69	84	81	111	106	191	167
Other Current Assets	515	575	577	579	634	758	742
Plant, Property, & Equipment, net	92	123	121	104	96	99	112
Total Noncurrent Assets	1,032	1,801	1,974	2,094	2,382	2,568	2,914
Long-Term Investments	64	69	69	111	107	128	139
Goodwill	737	1,047	1,262	1,413	1,662	1,793	2,083
Intangible Assets	180	260	246	208	254	276	350
Noncurrent Deferred & Refundable Income Taxes	5.68	130	130	134	138	140	133
Other Noncurrent Operating Assets	46	295	266	229	221	231	209
Total Liabilities & Shareholders' Equity	2,613	3,450	3,938	3,831	4,198	4,804	5,488
Total Liabilities	1,657	1,790	2,076	1,894	2,102	2,427	2,953
Total Current Liabilities	1,006	1,144	1,187	1,031	1,108	1,411	1,916
Short-Term Debt	-	0.00	50	-	59	0.00	463
Accounts Payable	226	217	226	196	201	243	208
Accrued Expenses	560	640	651	599	630	801	894
Current Deferred Revenue	209	231	202	172	213	301	290
Current Deferred & Payable Income Tax Liabilities	12	7.23	4.98	7.84	4.29	6.98	7.70
Other Current Liabilities	0.00	50	54	56	-	59	53
Total Noncurrent Liabilities	651	645	889	863	994	1,016	1,038
Long-Term Debt	429	249	540	592	744	746	784
Capital Lease Obligations	46	-	-	149	111	118	114
Noncurrent Deferred & Payable Income Tax Liabilities	6.24	9.62	12	11	12	9.78	11
Other Noncurrent Operating Liabilities	170	386	337	111	127	143	128
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-921	1,661	1,861	1,937	2,096	2,377	2,534
Total Preferred & Common Equity	-968	1,630	1,814	1,901	2,044	2,287	2,416
Total Common Equity	-968	1,630	1,814	1,901	2,044	2,287	2,416
Common Stock	0.00	2,796	2,848	2,831	2,863	2,926	2,831
Retained Earnings	12	-218	-121	-54	43	204	427
Treasury Stock	-957	-934	-899	-867	-845	-827	-815
Accumulated Other Comprehensive Income / (Loss)	-23	-14	-14	-9.57	-18	-15	-27
Noncontrolling Interest	46	31	48	36	52	90	118

This table presents Parsons' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	4,095	4,256	4,508	4,733	5,098	5,239	5,443	5,449
Total Current Assets	1,611	1,801	1,980	2,016	2,427	2,574	2,555	2,401
Cash & Equivalents	148	220	179	205	423	528	559	270
Accounts Receivable	711	764	949	907	1,023	1,043	1,035	1,125
Prepaid Expenses	110	134	140	147	213	199	171	184
Other Current Assets	642	684	712	757	768	804	790	823
Plant, Property, & Equipment, net	95	95	95	99	98	98	101	122
Total Noncurrent Assets	2,390	2,360	2,432	2,618	2,573	2,567	2,787	2,926
Long-Term Investments	99	107	119	165	145	157	195	142
Goodwill	1,661	1,662	1,693	1,797	1,791	1,791	1,931	2,107
Intangible Assets	273	236	240	282	262	248	308	340
Noncurrent Deferred & Refundable Income Taxes	140	140	145	149	158	163	164	132
Other Noncurrent Operating Assets	216	214	235	225	217	208	190	205
Total Liabilities & Shareholders' Equity	4,095	4,256	4,508	4,733	5,098	5,239	5,443	5,449
Total Liabilities	2,090	2,130	2,317	2,485	2,855	2,919	3,029	2,903
Total Current Liabilities	1,149	1,140	1,295	1,394	1,354	1,427	1,650	1,865
Short-Term Debt	-	56	57	57	55	53	115	435
Accounts Payable	201	209	237	266	274	253	300	289
Accrued Expenses	683	635	694	772	739	822	877	784
Current Deferred Revenue	198	229	292	277	283	298	-	298
Current Deferred & Payable Income Tax Liabilities	9.15	11	15	22	2.37	1.04	4.56	7.69
Other Current Liabilities	59	0.00	0.00	-	-	-	353	53
Total Noncurrent Liabilities	940	990	1,022	1,091	1,502	1,492	1,379	1,038
Long-Term Debt	695	744	745	820	1,246	1,247	1,133	785
Capital Lease Obligations	121	107	129	119	107	98	98	108
Noncurrent Deferred & Payable Income Tax Liabilities	10	13	20	20	9.76	9.79	28	11
Other Noncurrent Operating Liabilities	114	126	128	131	139	137	121	133
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,005	2,126	2,191	2,248	2,243	2,320	2,414	2,546
Total Preferred & Common Equity	1,953	2,064	2,119	2,173	2,150	2,219	2,312	2,454
Total Common Equity	1,953	2,064	2,119	2,173	2,150	2,219	2,312	2,454
Common Stock	2,825	2,858	2,868	2,876	2,907	2,909	2,929	2,807
Retained Earnings	15	68	112	159	87	156	227	488
Treasury Stock	-867	-845	-845	-845	-827	-827	-827	-815
Accumulated Other Comprehensive Income / (Loss)	-19	-18	-15	-17	-17	-19	-16	-26
Noncontrolling Interest	52	62	71	75	93	101	102	92

This table displays calculated financial ratios and metrics derived from Parsons' official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/29/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	18.01%	11.07%	-0.91%	-6.59%	14.60%	29.74%	24.03%
EBITDA Growth	0.00%	95.29%	-36.61%	45.49%	-12.02%	12.66%	33.40%	28.12%
EBIT Growth	0.00%	89.93%	-67.74%	102.50%	-28.47%	45.08%	55.68%	45.27%
NOPAT Growth	0.00%	49.50%	-0.63%	-30.22%	-20.12%	35.10%	60.61%	49.05%
Net Income Growth	0.00%	114.67%	-42.73%	-13.28%	-25.20%	42.28%	64.28%	39.80%
EPS Growth	0.00%	139.66%	-53.24%	-25.38%	-39.18%	47.46%	63.22%	49.30%
Operating Cash Flow Growth	0.00%	7.40%	-22.62%	31.29%	-28.91%	15.54%	71.64%	28.43%
Free Cash Flow Firm Growth	0.00%	0.00%	58.43%	68.31%	-89.23%	-23.23%	110.22%	-549.69%
Invested Capital Growth	0.00%	0.00%	51.63%	15.13%	17.31%	18.75%	7.53%	16.38%
Revenue Q/Q Growth	0.00%	0.00%	2.82%	-1.83%	-0.37%	3.77%	7.74%	3.69%
EBITDA Q/Q Growth	0.00%	0.00%	6.38%	7.69%	1.73%	3.00%	5.41%	2.13%
EBIT Q/Q Growth	0.00%	0.00%	1.56%	12.36%	1.63%	9.59%	6.84%	4.32%
NOPAT Q/Q Growth	0.00%	0.00%	1.07%	3.16%	11.07%	2.64%	8.52%	0.38%
Net Income Q/Q Growth	0.00%	0.00%	6.26%	4.02%	11.59%	0.16%	11.66%	119.78%
EPS Q/Q Growth	0.00%	0.00%	4.00%	4.30%	9.26%	-2.25%	11.81%	221.21%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-30.18%	42.41%	-29.46%	-0.29%	32.92%	-10.80%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-230.99%	26.52%	25.64%	130.88%	-161.99%
Invested Capital Q/Q Growth	0.00%	0.00%	0.94%	13.65%	7.62%	2.57%	-1.23%	9.87%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	20.45%	21.50%	21.03%	22.37%	23.30%	22.57%	22.16%	20.83%
EBITDA Margin	5.79%	9.58%	5.47%	8.03%	7.56%	7.44%	7.65%	7.90%
Operating Margin	5.00%	5.76%	2.33%	4.54%	3.62%	4.43%	5.30%	6.34%
EBIT Margin	4.85%	7.81%	2.27%	4.63%	3.55%	4.49%	5.39%	6.31%
Profit (Net Income) Margin	3.70%	6.72%	3.47%	3.03%	2.43%	3.02%	3.82%	4.31%
Tax Burden Percent	83.86%	92.16%	203.93%	73.68%	79.01%	76.14%	78.74%	79.06%
Interest Burden Percent	90.89%	93.48%	74.99%	88.89%	86.68%	88.21%	90.01%	86.27%
Effective Tax Rate	16.14%	7.84%	-103.93%	26.33%	20.99%	23.86%	21.26%	20.94%
Return on Invested Capital (ROIC)	0.00%	34.81%	13.75%	7.40%	5.08%	5.81%	8.29%	11.02%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	112.25%	-73.70%	-118.69%	-4.72%	2.25%	4.49%	3.26%
Return on Net Nonoperating Assets (RNNOA)	0.00%	15.33%	-3.26%	-0.65%	-0.40%	0.46%	1.01%	0.82%
Return on Equity (ROE)	0.00%	50.13%	10.48%	6.75%	4.68%	6.28%	9.30%	11.84%
Cash Return on Invested Capital (CROIC)	0.00%	-165.19%	-27.29%	-6.67%	-10.85%	-11.33%	1.03%	-4.12%
Operating Return on Assets (OROA)	0.00%	10.64%	2.96%	4.92%	3.34%	4.69%	6.52%	8.28%
Return on Assets (ROA)	0.00%	9.16%	4.52%	3.22%	2.29%	3.15%	4.62%	5.65%
Return on Common Equity (ROCE)	0.00%	-50.78%	2.65%	6.60%	4.58%	6.14%	9.00%	11.34%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-24.75%	8.41%	6.56%	4.68%	6.19%	9.09%	12.03%
Net Operating Profit after Tax (NOPAT)	126	189	188	131	105	141	227	338
NOPAT Margin	4.19%	5.31%	4.75%	3.34%	2.86%	3.37%	4.17%	5.01%
Net Nonoperating Expense Percent (NNEP)	0.00%	-77.45%	87.44%	126.09%	9.80%	3.57%	3.80%	7.75%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	4.70%	7.01%	8.69%
Cost of Revenue to Revenue	79.55%	78.50%	78.97%	77.63%	76.70%	77.43%	77.84%	79.17%
SG&A Expenses to Revenue	16.78%	16.78%	19.76%	18.60%	20.69%	18.53%	15.98%	14.15%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	15.45%	15.74%	18.70%	17.84%	19.68%	18.14%	16.86%	14.15%
Earnings before Interest and Taxes (EBIT)	146	278	90	182	130	188	293	426
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	175	341	216	315	277	312	416	533
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	2.51	2.02	1.81	2.34	2.88	4.05
Price to Tangible Book Value (P/TBV)	0.00	0.00	12.70	11.99	12.28	37.52	30.04	0.00
Price to Revenue (P/Rev)	0.17	0.14	1.04	0.94	0.94	1.14	1.21	1.45
Price to Earnings (P/E)	5.14	2.25	34.00	37.22	53.70	49.52	40.82	41.68
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	19.47%	44.47%	2.94%	2.69%	1.86%	2.02%	2.45%	2.40%
Enterprise Value to Invested Capital (EV/IC)	0.00	2.35	2.50	1.98	1.69	2.04	2.51	3.23
Enterprise Value to Revenue (EV/Rev)	0.00	0.72	1.04	0.96	1.03	1.28	1.31	1.58
Enterprise Value to EBITDA (EV/EBITDA)	0.00	7.48	19.02	11.91	13.59	17.26	17.13	20.04
Enterprise Value to EBIT (EV/EBIT)	0.00	9.19	45.88	20.65	28.98	28.57	24.30	25.07
Enterprise Value to NOPAT (EV/NOPAT)	0.00	13.51	21.91	28.62	35.97	38.08	31.40	31.57
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	8.97	18.68	12.96	18.31	22.67	17.49	20.40
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	253.23	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.50	0.15	0.32	0.38	0.44	0.36	0.54
Long-Term Debt to Equity	0.00	0.50	0.15	0.29	0.38	0.41	0.36	0.35
Financial Leverage	0.00	0.14	0.04	0.01	0.08	0.21	0.23	0.25
Leverage Ratio	0.00	2.74	2.32	2.10	2.05	1.99	2.01	2.10
Compound Leverage Factor	0.00	2.56	1.74	1.86	1.77	1.76	1.81	1.81
Debt to Total Capital	0.00%	33.22%	13.05%	24.07%	27.66%	30.37%	26.65%	34.95%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	2.04%	0.00%	1.96%	0.00%	11.89%
Long-Term Debt to Total Capital	0.00%	33.22%	13.05%	22.03%	27.66%	28.41%	26.65%	23.06%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	134.42%	1.62%	1.94%	1.36%	1.74%	2.76%	3.03%
Common Equity to Total Capital	0.00%	-67.64%	85.33%	73.99%	70.98%	67.89%	70.59%	62.02%
Debt to EBITDA	0.00	1.39	1.15	1.87	2.68	2.93	2.07	2.55
Net Debt to EBITDA	0.00	0.38	-0.07	0.11	1.03	1.74	1.11	1.44
Long-Term Debt to EBITDA	0.00	1.39	1.15	1.72	2.68	2.74	2.07	1.69
Debt to NOPAT	0.00	2.52	1.33	4.50	7.08	6.47	3.80	4.02
Net Debt to NOPAT	0.00	0.69	-0.08	0.26	2.74	3.85	2.04	2.27
Long-Term Debt to NOPAT	0.00	2.52	1.33	4.12	7.08	6.05	3.80	2.65
Altman Z-Score	0.00	2.12	2.65	2.36	2.33	2.70	3.20	3.70
Noncontrolling Interest Sharing Ratio	0.00%	201.29%	74.68%	2.23%	2.21%	2.20%	3.17%	4.23%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.48	1.33	1.55	1.58	1.55	1.52	1.29
Quick Ratio	0.00	0.90	0.75	1.00	0.91	0.88	0.84	0.81
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-897	-373	-118	-223	-275	28	-127
Operating Cash Flow to CapEx	1,031.68%	986.80%	345.16%	890.00%	1,039.51%	796.48%	1,023.08%	1,067.84%
Free Cash Flow to Firm to Interest Expense	0.00	-43.02	-15.71	-5.64	-12.63	-11.88	0.89	-1.81
Operating Cash Flow to Interest Expense	16.78	13.66	9.28	13.80	11.62	10.24	12.94	7.49
Operating Cash Flow Less CapEx to Interest Expense	15.15	12.27	6.59	12.25	10.50	8.96	11.68	6.79
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.00	1.36	1.30	1.06	0.94	1.05	1.21	1.31
Accounts Receivable Turnover	0.00	5.71	6.11	5.72	5.65	6.38	6.67	6.70
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	38.76	36.86	32.15	32.51	41.90	55.82	64.13
Accounts Payable Turnover	0.00	12.35	14.10	13.76	13.31	16.34	19.07	23.73
Days Sales Outstanding (DSO)	0.00	63.90	59.75	63.80	64.65	57.23	54.76	54.50
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	29.56	25.88	26.53	27.43	22.34	19.14	15.38
Cash Conversion Cycle (CCC)	0.00	34.34	33.86	37.27	37.23	34.89	35.62	39.12
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	0.00	1,086	1,646	1,895	2,223	2,640	2,839	3,304
Invested Capital Turnover	0.00	6.56	2.90	2.21	1.78	1.73	1.99	2.20
Increase / (Decrease) in Invested Capital	0.00	1,086	560	249	328	417	199	465
Enterprise Value (EV)	0.00	2,553	4,114	3,749	3,764	5,384	7,129	10,684
Market Capitalization	500	500	4,098	3,667	3,441	4,787	6,578	9,796
Book Value per Share	$0.00	($52.25)	$16.42	$18.01	$18.59	$19.74	$21.81	$22.76
Tangible Book Value per Share	$0.00	($101.74)	$3.25	$3.04	$2.74	$1.23	$2.09	($0.15)
Total Capital	0.00	1,430	1,910	2,451	2,678	3,010	3,240	3,896
Total Debt	0.00	475	249	590	741	914	863	1,362
Total Long-Term Debt	0.00	475	249	540	741	855	863	898
Net Debt	0.00	130	-15	34	286	544	462	770
Capital Expenditures (CapEx)	26	29	64	32	20	30	40	49
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	201	187	219	258	408	454	557
Debt-free Net Working Capital (DFNWC)	0.00	483	382	706	602	671	727	1,010
Net Working Capital (NWC)	0.00	483	382	656	602	612	727	547
Net Nonoperating Expense (NNE)	15	-50	51	12	16	15	19	48
Net Nonoperating Obligations (NNO)	0.00	130	-15	34	286	544	462	770
Total Depreciation and Amortization (D&A)	28	63	127	133	147	124	123	107
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	5.66%	4.72%	5.58%	7.04%	9.73%	8.34%	8.25%
Debt-free Net Working Capital to Revenue	0.00%	13.56%	9.66%	18.01%	16.43%	15.99%	13.35%	14.96%
Net Working Capital to Revenue	0.00%	13.56%	9.66%	16.73%	16.43%	14.58%	13.35%	8.10%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$1.30	$0.98	$0.62	$0.93	$1.53	$2.21
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	100.67M	102.36M	103.67M	104.71M	105.83M	106.78M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$1.30	$0.97	$0.59	$0.87	$1.42	$2.12
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	100.67M	102.36M	103.67M	104.71M	105.83M	106.78M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	100.67M	102.36M	103.67M	104.71M	105.83M	106.78M
Normalized Net Operating Profit after Tax (NOPAT)	126	189	64	131	105	141	227	338
Normalized NOPAT Margin	4.19%	5.31%	1.63%	3.34%	2.86%	3.37%	4.17%	5.01%
Pre Tax Income Margin	4.41%	7.30%	1.70%	4.12%	3.08%	3.96%	4.85%	5.45%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.26	13.34	3.78	8.66	7.34	8.13	9.31	6.09
NOPAT to Interest Expense	8.00	9.07	7.91	6.25	5.91	6.10	7.21	4.84
EBIT Less CapEx to Interest Expense	7.64	11.95	1.09	7.11	6.22	6.84	8.05	5.39
NOPAT Less CapEx to Interest Expense	6.37	7.68	5.22	4.70	4.80	4.81	5.94	4.14
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	46.05%	7.89%	68.82%	4.89%	42.64%	19.06%	6.01%	10.05%
Augmented Payout Ratio	46.05%	7.89%	73.40%	4.89%	67.04%	45.33%	11.30%	18.65%

This table displays calculated financial ratios and metrics derived from Parsons' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	18.65%	16.04%	23.64%	34.48%	25.05%	35.46%	30.87%	23.15%	27.60%	16.07%	1.22%
EBITDA Growth	20.27%	10.84%	32.68%	66.04%	21.86%	22.98%	56.09%	29.64%	25.15%	9.73%	28.22%
EBIT Growth	58.63%	36.25%	73.44%	134.25%	31.30%	30.27%	87.85%	45.89%	40.60%	21.83%	38.30%
NOPAT Growth	64.27%	8.25%	71.76%	129.45%	36.62%	40.50%	84.90%	45.78%	37.03%	23.67%	8.15%
Net Income Growth	62.86%	0.57%	47.95%	140.43%	37.20%	59.73%	-361.12%	47.38%	43.10%	272.86%	48.72%
EPS Growth	50.00%	-7.69%	21.05%	123.53%	55.56%	62.50%	-539.13%	65.79%	54.76%	374.36%	62.16%
Operating Cash Flow Growth	59.26%	-0.78%	65.04%	-54.99%	65.47%	113.25%	-605.45%	601.72%	46.89%	-33.33%	81.41%
Free Cash Flow Firm Growth	-24.61%	-29.69%	-358.79%	82.59%	49.08%	63.31%	41.45%	-0.01%	82.10%	-183.95%	1.99%
Invested Capital Growth	24.60%	18.75%	26.27%	6.85%	11.67%	7.53%	13.98%	7.38%	4.62%	16.38%	12.29%
Revenue Q/Q Growth	12.46%	-2.76%	6.38%	15.60%	4.58%	5.33%	2.77%	8.78%	8.36%	-4.19%	-10.38%
EBITDA Q/Q Growth	45.96%	-0.69%	-12.33%	30.66%	7.12%	0.22%	11.27%	8.52%	3.41%	-12.12%	11.25%
EBIT Q/Q Growth	92.69%	-2.08%	-15.43%	46.80%	8.00%	-2.85%	21.96%	14.01%	4.09%	-15.82%	12.65%
NOPAT Q/Q Growth	86.53%	-8.92%	-12.95%	55.14%	11.06%	-6.33%	14.56%	22.32%	4.39%	-15.47%	15.21%
Net Income Q/Q Growth	91.37%	-16.63%	-2.95%	55.26%	9.20%	-2.93%	-258.66%	187.63%	6.03%	152.92%	-62.22%
EPS Q/Q Growth	58.82%	-11.11%	-4.17%	65.22%	10.53%	-7.14%	-358.97%	162.38%	3.17%	184.62%	-67.57%
Operating Cash Flow Q/Q Growth	141.00%	-27.53%	-110.08%	355.57%	786.06%	-6.61%	-133.36%	354.22%	85.47%	-57.61%	-109.30%
Free Cash Flow Firm Q/Q Growth	33.98%	18.94%	-40.75%	76.88%	-93.02%	41.58%	-57.23%	60.51%	65.45%	-826.63%	25.17%
Invested Capital Q/Q Growth	-2.60%	2.57%	2.45%	4.40%	1.79%	-1.23%	6.40%	-1.65%	-0.82%	9.87%	4.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	23.09%	22.00%	21.84%	21.25%	20.74%	24.57%	21.15%	21.04%	19.90%	21.32%	22.77%
EBITDA Margin	8.25%	8.42%	6.94%	7.85%	8.04%	7.65%	8.28%	8.26%	7.88%	7.23%	8.97%
Operating Margin	5.64%	5.34%	4.36%	5.64%	5.87%	5.18%	6.63%	6.67%	6.35%	5.76%	7.03%
EBIT Margin	5.58%	5.62%	4.47%	5.68%	5.86%	5.41%	6.42%	6.72%	6.46%	5.67%	7.13%
Profit (Net Income) Margin	3.84%	3.30%	3.01%	4.04%	4.22%	3.89%	-6.00%	4.83%	4.73%	12.48%	5.26%
Tax Burden Percent	75.97%	75.16%	75.41%	78.25%	79.72%	80.35%	74.08%	78.27%	79.17%	77.10%	81.17%
Interest Burden Percent	90.62%	77.99%	89.20%	90.92%	90.23%	89.44%	-126.22%	91.82%	92.47%	285.27%	90.89%
Effective Tax Rate	24.03%	24.84%	24.59%	21.75%	20.28%	19.65%	0.00%	21.73%	20.83%	22.90%	18.83%
Return on Invested Capital (ROIC)	7.47%	6.93%	5.99%	7.69%	8.68%	8.27%	9.31%	10.91%	11.13%	9.75%	11.80%
ROIC Less NNEP Spread (ROIC-NNEP)	6.18%	5.01%	5.14%	6.92%	7.58%	7.44%	-13.71%	9.95%	10.24%	32.40%	11.02%
Return on Net Nonoperating Assets (RNNOA)	1.25%	1.03%	0.97%	2.18%	2.13%	1.68%	-4.46%	2.97%	2.68%	8.13%	4.04%
Return on Equity (ROE)	8.72%	7.96%	6.96%	9.88%	10.81%	9.95%	4.86%	13.88%	13.81%	17.88%	15.84%
Cash Return on Invested Capital (CROIC)	-15.97%	-11.33%	-16.72%	0.38%	-3.35%	1.03%	-2.92%	3.67%	6.94%	-4.12%	-1.02%
Operating Return on Assets (OROA)	5.70%	5.87%	4.90%	6.28%	6.71%	6.54%	7.96%	8.44%	8.26%	7.44%	9.16%
Return on Assets (ROA)	3.92%	3.44%	3.29%	4.47%	4.83%	4.70%	-7.44%	6.07%	6.05%	16.37%	6.75%
Return on Common Equity (ROCE)	8.54%	7.78%	6.80%	9.62%	10.49%	9.63%	4.68%	13.35%	13.29%	17.12%	15.23%
Return on Equity Simple (ROE_SIMPLE)	6.47%	0.00%	6.69%	8.02%	8.57%	0.00%	3.75%	4.80%	5.72%	0.00%	12.94%
Net Operating Profit after Tax (NOPAT)	49	44	39	60	66	62	71	87	91	77	89
NOPAT Margin	4.29%	4.02%	3.29%	4.41%	4.68%	4.16%	4.64%	5.22%	5.03%	4.44%	5.70%
Net Nonoperating Expense Percent (NNEP)	1.29%	1.91%	0.85%	0.77%	1.11%	0.83%	23.02%	0.96%	0.89%	-22.65%	0.78%
Return On Investment Capital (ROIC_SIMPLE)	-	1.47%	-	-	-	1.92%	-	-	-	1.98%	2.29%
Cost of Revenue to Revenue	76.91%	78.00%	78.16%	78.75%	79.26%	75.43%	78.85%	78.96%	80.10%	78.68%	77.23%
SG&A Expenses to Revenue	17.36%	17.72%	16.98%	15.62%	15.59%	15.90%	14.39%	13.37%	13.60%	15.26%	15.70%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	17.45%	16.66%	17.48%	15.62%	14.87%	19.39%	14.52%	14.37%	13.55%	14.22%	15.75%
Earnings before Interest and Taxes (EBIT)	63	62	52	77	83	81	99	112	117	98	111
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	94	93	81	106	114	114	127	138	143	125	139
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.08	2.34	2.27	2.38	2.62	2.88	4.05	5.41	4.76	4.05	2.58
Price to Tangible Book Value (P/TBV)	219.24	37.52	28.25	27.08	61.09	30.04	90.28	66.87	150.11	0.00	894.62
Price to Revenue (P/Rev)	1.00	1.14	1.06	1.06	1.13	1.21	1.50	1.96	1.69	1.45	0.93
Price to Earnings (P/E)	41.63	49.52	46.13	39.91	39.48	40.82	308.08	221.62	139.93	41.68	24.18
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.40%	2.02%	2.17%	2.51%	2.53%	2.45%	0.32%	0.45%	0.71%	2.40%	4.14%
Enterprise Value to Invested Capital (EV/IC)	1.82	2.04	1.97	2.04	2.23	2.51	3.12	4.23	3.89	3.23	2.12
Enterprise Value to Revenue (EV/Rev)	1.16	1.28	1.21	1.21	1.27	1.31	1.66	2.10	1.80	1.58	1.08
Enterprise Value to EBITDA (EV/EBITDA)	15.45	17.26	16.04	15.37	16.22	17.13	20.86	25.98	22.42	20.04	13.00
Enterprise Value to EBIT (EV/EBIT)	27.22	28.57	25.28	22.58	23.32	24.30	28.38	34.21	28.65	25.07	16.05
Enterprise Value to NOPAT (EV/NOPAT)	33.98	38.08	33.80	30.06	30.60	31.40	32.79	40.58	34.72	31.57	21.22
Enterprise Value to Operating Cash Flow (EV/OCF)	19.65	22.67	20.95	25.43	20.87	17.49	27.27	26.08	19.94	20.40	12.74
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	555.74	0.00	253.23	0.00	119.26	57.31	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.41	0.44	0.43	0.42	0.44	0.36	0.63	0.60	0.56	0.54	0.52
Long-Term Debt to Equity	0.41	0.41	0.40	0.40	0.42	0.36	0.60	0.58	0.51	0.35	0.35
Financial Leverage	0.20	0.21	0.19	0.32	0.28	0.23	0.32	0.30	0.26	0.25	0.37
Leverage Ratio	2.05	1.99	1.98	2.07	2.08	2.01	2.14	2.16	2.18	2.10	2.20
Compound Leverage Factor	1.86	1.55	1.76	1.89	1.87	1.80	-2.70	1.98	2.02	5.98	2.00
Debt to Total Capital	28.92%	30.37%	29.91%	29.81%	30.71%	26.65%	38.57%	37.61%	35.80%	34.95%	34.29%
Short-Term Debt to Total Capital	0.00%	1.96%	1.83%	1.83%	1.75%	0.00%	1.51%	1.42%	3.07%	11.89%	11.23%
Long-Term Debt to Total Capital	28.92%	28.41%	28.08%	27.98%	28.96%	26.65%	37.06%	36.19%	32.73%	23.06%	23.06%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.84%	1.74%	2.03%	2.29%	2.32%	2.76%	2.56%	2.72%	2.71%	3.03%	2.37%
Common Equity to Total Capital	69.23%	67.89%	68.05%	67.90%	66.96%	70.59%	58.87%	59.67%	61.49%	62.02%	63.34%
Debt to EBITDA	2.69	2.93	2.73	2.49	2.52	2.07	3.05	2.83	2.58	2.55	2.36
Net Debt to EBITDA	1.88	1.74	1.74	1.69	1.59	1.11	1.82	1.44	1.14	1.44	1.63
Long-Term Debt to EBITDA	2.69	2.74	2.56	2.33	2.38	2.07	2.93	2.73	2.36	1.69	1.58
Debt to NOPAT	5.92	6.47	5.76	4.86	4.76	3.80	4.79	4.43	3.99	4.02	3.84
Net Debt to NOPAT	4.13	3.85	3.68	3.31	2.99	2.04	2.86	2.26	1.76	2.27	2.65
Long-Term Debt to NOPAT	5.92	6.05	5.41	4.56	4.49	3.80	4.61	4.26	3.65	2.65	2.59
Altman Z-Score	2.34	2.60	2.61	2.64	2.71	3.06	3.31	4.01	3.71	3.51	2.86
Noncontrolling Interest Sharing Ratio	2.12%	2.20%	2.31%	2.59%	3.00%	3.17%	3.55%	3.82%	3.80%	4.23%	3.87%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.40	1.55	1.58	1.53	1.45	1.52	1.79	1.80	1.55	1.29	1.29
Quick Ratio	0.75	0.88	0.86	0.87	0.80	0.84	1.07	1.10	0.97	0.81	0.75
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-459	-372	-524	-121	-234	-137	-307	-121	-42	-388	-290
Operating Cash Flow to CapEx	2,094.52%	840.24%	-110.62%	235.31%	1,601.48%	2,056.16%	-672.25%	1,750.37%	2,561.75%	677.31%	-87.49%
Free Cash Flow to Firm to Interest Expense	-72.67	-44.35	-81.18	-16.61	-27.17	-14.97	-1.37	-9.32	-3.21	0.00	-23.71
Operating Cash Flow to Interest Expense	19.46	10.62	-1.39	3.15	23.64	20.83	-0.28	12.39	22.94	0.00	-0.96
Operating Cash Flow Less CapEx to Interest Expense	18.53	9.35	-2.65	1.81	22.16	19.82	-0.33	11.69	22.05	0.00	-2.06
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.02	1.05	1.10	1.11	1.14	1.21	1.24	1.26	1.28	1.31	1.28
Accounts Receivable Turnover	6.04	6.38	6.27	5.67	6.25	6.67	6.50	6.14	6.71	6.70	6.30
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	40.35	41.90	45.88	49.21	52.12	55.82	60.07	63.25	64.93	64.13	61.47
Accounts Payable Turnover	15.97	16.34	18.73	17.22	17.00	19.07	18.74	19.51	18.03	23.73	18.96
Days Sales Outstanding (DSO)	60.41	57.23	58.22	64.43	58.43	54.76	56.19	59.43	54.43	54.50	57.92
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	22.85	22.34	19.49	21.20	21.48	19.14	19.48	18.71	20.25	15.38	19.25
Cash Conversion Cycle (CCC)	37.56	34.89	38.72	43.23	36.96	35.62	36.71	40.72	34.18	39.12	38.67
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,574	2,640	2,705	2,824	2,874	2,839	3,083	3,032	3,007	3,304	3,462
Invested Capital Turnover	1.74	1.73	1.82	1.74	1.85	1.99	2.01	2.09	2.21	2.20	2.07
Increase / (Decrease) in Invested Capital	508	417	563	181	300	199	378	208	133	465	379
Enterprise Value (EV)	4,681	5,384	5,326	5,752	6,402	7,129	9,634	12,819	11,704	10,684	7,331
Market Capitalization	4,060	4,787	4,685	5,048	5,701	6,578	8,701	12,005	11,009	9,796	6,322
Book Value per Share	$18.86	$19.74	$19.71	$20.21	$20.72	$21.81	$14.65	$15.12	$21.78	$22.76	$22.98
Tangible Book Value per Share	$0.18	$1.23	$1.58	$1.78	$0.89	$2.09	$0.66	$1.22	$0.69	($0.15)	$0.07
Total Capital	2,821	3,010	3,033	3,121	3,245	3,240	3,651	3,718	3,761	3,896	3,874
Total Debt	816	914	907	930	997	863	1,408	1,398	1,346	1,362	1,328
Total Long-Term Debt	816	855	852	873	940	863	1,353	1,345	1,231	898	894
Net Debt	569	544	579	633	626	462	840	713	593	770	916
Capital Expenditures (CapEx)	5.87	11	8.13	9.76	13	9.25	9.43	9.21	12	19	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	314	408	496	564	473	454	705	671	462	557	701
Debt-free Net Working Capital (DFNWC)	461	671	717	742	678	727	1,129	1,200	1,021	1,010	971
Net Working Capital (NWC)	461	612	661	685	621	727	1,074	1,147	905	547	536
Net Nonoperating Expense (NNE)	5.03	7.94	3.28	5.05	6.63	4.17	163	6.49	5.45	-140	6.87
Net Nonoperating Obligations (NNO)	569	544	579	633	626	462	840	713	593	770	916
Total Depreciation and Amortization (D&A)	30	31	29	29	31	33	29	26	26	27	29
Debt-free, Cash-free Net Working Capital to Revenue	7.76%	9.73%	11.23%	11.83%	9.36%	8.34%	12.15%	10.97%	7.09%	8.25%	10.35%
Debt-free Net Working Capital to Revenue	11.41%	15.99%	16.22%	15.57%	13.43%	13.35%	19.44%	19.60%	15.68%	14.96%	14.34%
Net Working Capital to Revenue	11.41%	14.58%	14.96%	14.37%	12.30%	13.35%	18.49%	18.74%	13.90%	8.10%	7.91%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.29	$0.26	$0.24	$0.41	$0.45	$0.43	($1.01)	$0.65	$0.68	$1.89	$0.62
Adjusted Weighted Average Basic Shares Outstanding	103.50M	104.71M	104.86M	104.89M	104.89M	105.83M	146.75M	106.19M	106.19M	106.78M	106.87M
Adjusted Diluted Earnings per Share	$0.27	$0.24	$0.23	$0.38	$0.42	$0.39	($1.01)	$0.63	$0.65	$1.85	$0.60
Adjusted Weighted Average Diluted Shares Outstanding	103.50M	104.71M	104.86M	104.89M	104.89M	105.83M	146.75M	106.19M	106.19M	106.78M	106.87M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	103.50M	104.71M	104.86M	104.89M	104.89M	105.83M	146.75M	106.19M	106.19M	106.78M	106.87M
Normalized Net Operating Profit after Tax (NOPAT)	49	44	39	60	66	62	71	87	91	77	89
Normalized NOPAT Margin	4.29%	4.02%	3.29%	4.41%	4.68%	4.16%	4.64%	5.22%	5.03%	4.44%	5.70%
Pre Tax Income Margin	5.06%	4.38%	3.99%	5.16%	5.29%	4.84%	-8.10%	6.17%	5.97%	16.19%	6.48%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	10.02	7.38	8.12	10.55	9.66	8.85	0.44	8.63	8.97	0.00	9.05
NOPAT to Interest Expense	7.69	5.27	5.97	8.20	7.71	6.82	0.32	6.70	6.98	0.00	7.24
EBIT Less CapEx to Interest Expense	9.09	6.12	6.86	9.21	8.18	7.84	0.40	7.93	8.07	0.00	7.95
NOPAT Less CapEx to Interest Expense	6.76	4.01	4.71	6.86	6.24	5.80	0.28	6.00	6.09	0.00	6.14
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	11.85%	19.06%	11.93%	9.57%	11.81%	6.01%	28.71%	23.72%	22.19%	10.05%	18.88%
Augmented Payout Ratio	46.47%	45.33%	36.34%	18.07%	17.45%	11.30%	34.92%	35.93%	32.02%	18.65%	34.63%

Frequently Asked Questions About Parsons' Financials

When does Parsons's financial year end?

According to the most recent income statement we have on file, Parsons' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Parsons' net income changed over the last 7 years?

Parsons' net income appears to be on an upward trend, with a most recent value of $290.67 million in 2024, rising from $111.54 million in 2017. The previous period was $207.92 million in 2023. Find out what analysts predict for Parsons in the coming months.

What is Parsons's operating income?

Parsons's total operating income in 2024 was $428.07 million, based on the following breakdown:

Total Gross Profit: $1.41 billion
Total Operating Expenses: $955.00 million

How has Parsons revenue changed over the last 7 years?

Over the last 7 years, Parsons' total revenue changed from $3.02 billion in 2017 to $6.75 billion in 2024, a change of 123.8%.

How much debt does Parsons have?

Parsons' total liabilities were at $2.95 billion at the end of 2024, a 21.7% increase from 2023, and a 78.2% increase since 2018.

How much cash does Parsons have?

In the past 6 years, Parsons' cash and equivalents has ranged from $182.69 million in 2019 to $483.61 million in 2020, and is currently $453.55 million as of their latest financial filing in 2024.

How has Parsons' book value per share changed over the last 7 years?

Over the last 7 years, Parsons' book value per share changed from 0.00 in 2017 to 22.76 in 2024, a change of 2,275.5%.

Related Companies

This page (NYSE:PSN) was last updated on 5/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Parsons (PSN) Financials

Frequently Asked Questions About Parsons' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Parsons (PSN) Financials

Annual Income Statements for Parsons

Quarterly Income Statements for Parsons

Annual Cash Flow Statements for Parsons

Quarterly Cash Flow Statements for Parsons

Annual Balance Sheets for Parsons

Quarterly Balance Sheets for Parsons

Annual Metrics and Ratios for Parsons

Quarterly Metrics and Ratios for Parsons

Frequently Asked Questions About Parsons' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools